Acotec Scientific Holdings Limited has expanded its Scientific Advisory Board by inviting four more top physicians, Prof. Peter Schneider, Dr. Matthew T. Menard, Dr. Sahil A. Parikh, and Prof. Thomas Zeller to join. The Scientific Advisory Board will provide guidance to and lead the execution of the Company's global study for below-the-knee (BTK) drug-coated balloons (DCB) products indication expansion in the U.S. and Europe ("AcoArt BTK Global IDE Study") for the purpose of registration with U.S. Food and Drug Administration (FDA) in the U.S. Meanwhile, the Scientific Advisory Board will also provide input and feedback to guide the Company's new product development in peripheral intervention space and will support the Company's physician education both in China and in global market. Dr. Matthew T. Menard is a Castle Connolly Top Doctor whose specialty is vascular surgery and is located in Boston, MA. He is the director of the vascular and endovascular fellowship program and co-director of the Endovascular Surgery Program at Brigham and Women's Hospital's (BWH). He is a vascular and endovascular surgeon at BWH and an assistant professor of surgery at Harvard Medical School (HMS). Dr. Matthew T. Menard is also the co-principal investigator for Best Endovascular vs. Best Surgical Therapy in Patients with Critical Limb Ischemia (BEST-CLI), which is an international research study aimed at figuring out the best treatment for people with peripheral arterial disease (PAD) and associated with Critical Limb Ischemia (CLI). BEST-CLI is Federally funded by the National Heart, Lung and Blood Institute at the National Institutes of Health of U.S. Dr. Sahil A. Parikh is the Director of Endovascular Services at Columbia University Irving Medical Center and Associate Professor of Medicine at the Columbia University College of Physicians and Surgeons in New York City. Dr. Sahil A. Parikh has an active practice in cardiovascular medicine with a focus on atherosclerotic vascular disease and intervention throughout the circulation. He has won a number of teaching awards locally and co-directs several national educational programs for physicians in training and for continuing medical education in conjunction with the Cardiovascular Research Foundation, the American College of Cardiology, and the Society for Cardiovascular Angiography and Interventions. He has been the site and national principal investigator for several clinical trials and has authored more than 50 original manuscripts and reviews in basic and clinical cardiovascular medicine. Prof. Thomas Zeller is the Head of the Department of Angiology at the University Heart Center Freiburg/Bad Krozingen in Germany. He is an internationally recognized expert in endovascular interventions with a research focus on the development and testing of new interventional technologies for complex endovascular interventions. He has been principle investigator of numerous clinical trials including several studies on DCB technologies such as Thunder and the In.Pact series of clinical projects leading to US approval of Medtronic's IN. PACT Admiral DCB in femoropopliteal arteries.